Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

RGNXRGNX
Showing 8 of 15 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in REGENXBIO INC

Qube Research & Technologies Ltd holds 1.3M shares of RGNX (REGENXBIO INC), worth $11M as of 2026-Q1. The position was increased (+196.0% shares). RGNX represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$11M

Current Shares

1.3M

Total Value Change

+$9.7M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.3M
+196.0%
$11M0.0%$8.69
45
2025-Q4
Increased
442,690
+55.4%
$6.4M0.0%$14.09
38
2025-Q3
Decreased
284,831
-37.7%
$2.7M0.0%$9.85
0
2025-Q2
Increased
457,112
+16.4%
$3.8M0.0%$8.39
31
2025-Q1
Increased
392,795
+11.0%
$2.8M0.0%$7.83
29
2024-Q4
Increased
353,993
+82.4%
$2.7M0.0%$7.23
40
2024-Q3
Increased
194,074
+76.5%
$2M0.0%$10.80
39
2024-Q2
Increased
109,982
+155.9%
$1.3M0.0%$11.70
41

Other major holders of RGNX: BlackRock Finance, Inc., BlackRock, Inc., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used